Pharmacology - Block 1 Flashcards
Competitive antagonists - EC50 and Emax
Shift EC50 right, Emax no change
Irreversible or non-competitive antagonists - EC50 and Emax
EC50 no change, Emax lower
Acidic drugs ion trap on the ___
Basic side
pKa - pH =
pKa-pH = log(protonated/unprotonated)
Active transport enzyme pumps drugs back out
P-glycoprotein (MDR-1, ABC group)
Acidic drugs circulate with
Albumin (liver disease-> need lower dose)
Basic drugs circulate with
alpha1-glycoprotein (Crohn’s disease-> need larger dose)
Brain efflux transporters
P-glycoprotein and OATP
Fetal plasma and breast milk are more acid/base
acidic
Dose, concentration, vol of dist, bioavailability eqn
Dose = Vd*Co/F
T1/2 =
T1/2 = .69/Kel T1/2 = .69*Vd/CL
Slope of logC vs Time
slope = -Kel/2.3
CL =
CL = Vd*Kel
Maintence Dose / Interval =
Maintence Dose / Interval = Css*CL/F
Phase I enzymes located in
smooth ER
Phase II enzymes located in
cytosol
Cytochrome P450s in descending percentage of drugs metabolized
CYP3A (50%)
CYP2D6 (25%)
CYP2C9 (15%)
1A2, 2E1, 2C19
Most ubiquitous protein in liver
FMO3
Phase I enzymes need
NADPH
List Phase II enzymes
UGT (Glucuronidation)
SULT (Sulfation)
NAT (Acetylation)
Glutithione S-transferases
Ethanol induces
CYP2E1
Grapefruit juice inhibits
CYP3A
Can be inhibited near 0
CYP2D6
Not induced or inhibited
FMOs
When induced leads to APAP toxicity
2E1
NAT-2 (metabolizes, effect of dysfunction)
isoniazid (TB drug)
increased neuropathy
CYP2D6 (metabolizes, effect of dysfunction)
antidepressants
codeine->morphine
also, gene duplication-> ultra-fast
CYP2C19 (metabolizes, effect of dysfunction)
phenytoin (anti-convulsant)
omeprazole (PPI)
clopidogrel (activated by 2C19, anti-platelet)
CYP2C9 (metabolizes, effect of dysfunction)
Warfarin (anti-coagulant)
*3 has bigger impact than *2
Vit K Receptor (VKORC1) (drug, effect, clades)
Warfarin inhibits VKORC1,
A-clade=lower dose, B-clade=higher dose
Pseudocholinesterase (metabolizes, effect of dysfunction)
succinylcholine (muscle relaxant)
TPMT (metabolizes, effect of dysfunction)
6-mercaptopurine (6MP) (cancer drug)
P-glycoprotein (drug, effect)
digoxin (cardiac glycoside) (dysfunction increases net uptake)
Example of Intracellular steroid receptors
cortisol (travels with CBG) -> diffuses to cytosol, binds to glucocorticoid receptor (GR) -> conformational change releases inhibitory proteins -> binds to GRE on DNA promoter
GABA receptor agonist drugs
Benzodiazepines (valium)
Barbiturates (Phenobarbital)
Inositol-lipid pathway
GPCR->Gaq-GTP activates PLC -> PLC cleaves PIP2 to IP3 + DAG -> IP3 releases Ca from ER, DAG activates PKC
cAMP pathway
GPCR->Gas->adenylyl cyclase->cAMP->PKA->CREB->gene transcription
Monomeric G proteins are activated by / turned off by
ON: GEF
OFF: GAP
receptor linked tyrosine kinases
MAPKKK cascade
RAS-GTP->Raf->MKK1->ERK->phosphorylates transcription factors
Tyrosine kinase inhibitors (EGF receptor)
gefitinib
erlotinib
dopamine transported into storage vesicles by
VMAT2, vesicular monoamine transporter 2
Metabolic degradation of NE by
Monoamine Oxidase (MAO) catechol-O-methyltransferase (COMT)
Acetylcholine release inhibited by
botulinum toxin
alpha1 receptor
Gq - activate PLC
eye (iris), vascular, smooth muscle, vas deferens
contraction and ejaculation
alpha2 receptor
Gi - inhibit AC (cAMP), activate PLC in vascular SM
pre-synaptic nerve terminals, CNS
decrease NE release, decrease sympathetic outflow
beta1 receptor
Gs - activate AC (cAMP)
cardiac muscle, kidney
increase force, rate, renin release
beta2 receptor
Gs - activate AC (cAMP)
arteries, skeletal muscle, liver, bronchi
dilation, glycogenolysis
beta3 receptor
Gs - activate AC (cAMP)
adipose tissue
lipolysis
Norepinephrine uptake (by NET) blocked by
cocaine
Dopamine1 receptor
Kidney - dilation of kidney vasculature
Norepinephrine
Adrenergic agonist - direct
Catecholamine
a1, a2, b1
mainly a1 -> cardio effects -> peripheral vasoconstriction, up BP, can cause reflex bradycardia
Epinephrine
Adrenergic agonist - direct
Catecholamine
a1, a2, b1, b2
mainly B2 -> cardio effects -> up HR, up CO, increase systolic, decrease diastolic BP, constrict most vasculature but dilate skeletal muscle vasculature, decrease peripheral resistance
Bronchodilation
Hyperglycemia and lipolysis
rapid hypersensitivity relief, co-admin w/ local anesthetic, ophthalmic uses, bradyarrhythmias